Related Experiment Video
Updated: May 4, 2026

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
Published on: March 14, 2014
Gastrointestinal basidiobolomycosis treated with posaconazole
Stacey R Rose1, Mark D Lindsley2, Steven F Hurst2
1Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 10 Center Drive, Bethesda 20892, USA.
A rare fungal infection, basidiobolomycosis, caused an abdominal mass and obstruction in a patient. Treatment with posaconazole successfully reduced the mass, relieved symptoms, and resolved eosinophilia.
Area of Science:
- Mycology
- Gastroenterology
- Infectious Diseases
Background:
- Basidiobolomycosis is a rare fungal infection caused by Basidiobolus ranarum.
- It typically affects the gastrointestinal tract, presenting as an abdominal mass.
- This case highlights an unusual presentation involving intestinal obstruction and hydronephrosis.
Purpose of the Study:
- To report a case of basidiobolomycosis presenting with intestinal obstruction and hydronephrosis.
- To describe the diagnostic process, including histopathology and PCR identification of Basidiobolus ranarum.
- To evaluate the efficacy of posaconazole in treating this condition.
Main Methods:
- Surgical exploration and histopathological examination of the abdominal mass.
- Polymerase Chain Reaction (PCR) and sequencing for fungal identification.
- Clinical monitoring of patient response to posaconazole treatment.
Main Results:
- Histopathology confirmed basidiobolomycosis.
- PCR identified the causative agent as Basidiobolus ranarum.
- One year of posaconazole treatment led to mass reduction, relief of hydronephrosis, and resolution of peripheral eosinophilia.
Conclusions:
- Basidiobolomycosis can present with indolent gastrointestinal symptoms and significant complications like obstruction.
- Accurate identification of Basidiobolus ranarum is crucial for appropriate treatment.
- Posaconazole is an effective therapeutic option for managing basidiobolomycosis.
More Related Videos
Related Concept Videos
Antifungal Agents
Fungal Phylum Basidiomycota
Fungal Group Zygomycota
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Fungal Phylum Microsporidia

